Literature DB >> 1721376

FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS).

K V Lieberman1, W G Lin, L Reisman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721376

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.

Authors:  P S Randhawa; R Shapiro; M L Jordan; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

2.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

3.  Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.

Authors:  P S Randhawa; A C Tsamandas; M Magnone; M Jordan; R Shapiro; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1996-03       Impact factor: 6.394

Review 4.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

5.  Adult Renal Transplantation in a Patient 28 Years after Heart Transplantation as a Neonate for Hypoplastic Left Heart Syndrome.

Authors:  Joseph Licata; Shane Michael Roberts; Piotr Janicki; Dmitri Bezinover
Journal:  Case Rep Transplant       Date:  2022-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.